menu search

Beam therapeutics to present at the svb leerink 11th annual global healthcare conference

CAMBRIDGE, Mass., Feb. 09, 2022 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medici...

February 9, 2022, 6:30 am

Beam therapeutics to present at the svb leerink 11th annual global healthcare conference

CAMBRIDGE, Mass., Feb. 09, 2022 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medici...

February 9, 2022, 6:30 am

biotech etfs muddled despite amgen strength

Biotechnology sector-specific exchange traded funds were flat after Amgen (NasdaqGS: AMGN) provided a mixed earnings report but announced that it will...

February 8, 2022, 7:20 pm

biotech etfs muddled despite amgen strength

Biotechnology sector-specific exchange traded funds were flat after Amgen (NasdaqGS: AMGN) provided a mixed earnings report but announced that it will...

February 8, 2022, 7:20 pm

biotech etfs muddled despite amgen strength

Biotechnology sector-specific exchange traded funds were flat after Amgen (NasdaqGS: AMGN) provided a mixed earnings report but announced that it will...

February 8, 2022, 7:20 pm

Why shares of pfizer fell 10.8% in january

The company had a record year in financials, but some investors are concerned about the biotech stock's...

February 8, 2022, 3:52 pm

Why shares of pfizer fell 10.8% in january

The company had a record year in financials, but some investors are concerned about the biotech stock's...

February 8, 2022, 3:52 pm

Why shares of pfizer fell 10.8% in january

The company had a record year in financials, but some investors are concerned about the biotech stock's...

February 8, 2022, 3:52 pm

Flies for breakfast? archer-daniels partners with biotech company to bring insects to pet food with human food on the horizon

Black soldier flies for breakfast, lunch or dinner? Paris-based biotech company InnovaFeed is investing...

February 8, 2022, 1:41 pm

Flies for breakfast? archer-daniels partners with biotech company to bring insects to pet food with human food on the horizon

Black soldier flies for breakfast, lunch or dinner? Paris-based biotech company InnovaFeed is investing...

February 8, 2022, 1:41 pm

Flies for breakfast? archer-daniels partners with biotech company to bring insects to pet food with human food on the horizon

Black soldier flies for breakfast, lunch or dinner? Paris-based biotech company InnovaFeed is investing...

February 8, 2022, 1:41 pm

Ani pharmaceuticals: back in the buy zone

Today, we revisit specialty pharmaceutical concern ANI Pharmaceuticals for the first time since spring. The company has seen some positive news flow s...

February 8, 2022, 1:38 pm

Ani pharmaceuticals: back in the buy zone

Today, we revisit specialty pharmaceutical concern ANI Pharmaceuticals for the first time since spring. The company has seen some positive news flow s...

February 8, 2022, 1:38 pm

Ani pharmaceuticals: back in the buy zone

Today, we revisit specialty pharmaceutical concern ANI Pharmaceuticals for the first time since spring. The company has seen some positive news flow s...

February 8, 2022, 1:38 pm

Wall street analysts believe vir biotechnology, inc. (vir) could rally 157%: here's is how to trade

The mean of analysts' price targets for Vir Biotechnology, Inc. (VIR) points to a 156.8% upside in the stock. While this highly sought-after metric ha...

February 8, 2022, 11:30 am

Wall street analysts believe vir biotechnology, inc. (vir) could rally 157%: here's is how to trade

The mean of analysts' price targets for Vir Biotechnology, Inc. (VIR) points to a 156.8% upside in the stock. While this highly sought-after metric ha...

February 8, 2022, 11:30 am

Wall street analysts believe vir biotechnology, inc. (vir) could rally 157%: here's is how to trade

The mean of analysts' price targets for Vir Biotechnology, Inc. (VIR) points to a 156.8% upside in the stock. While this highly sought-after metric ha...

February 8, 2022, 11:30 am

Enveric biosciences advancing clinical plans as it announces two new molecules to treat osteoarthritis and other pain conditions

Enveric Biosciences (NASDAQ:ENVB) said that two new molecules, EV104a and EV104b, have been created to treat osteoarthritis (OA) along with other pai...

February 8, 2022, 8:55 am

Enveric biosciences advancing clinical plans as it announces two new molecules to treat osteoarthritis and other pain conditions

Enveric Biosciences (NASDAQ:ENVB) said that two new molecules, EV104a and EV104b, have been created to treat osteoarthritis (OA) along with other pai...

February 8, 2022, 8:55 am

Enveric biosciences advancing clinical plans as it announces two new molecules to treat osteoarthritis and other pain conditions

Enveric Biosciences (NASDAQ:ENVB) said that two new molecules, EV104a and EV104b, have been created to treat osteoarthritis (OA) along with other pai...

February 8, 2022, 8:55 am


Search within

Pages Search Results: